156 related articles for article (PubMed ID: 34741931)
1. Moving Ru polypyridyl complexes beyond cytotoxic activity towards metastasis inhibition.
Brindell M; Gurgul I; Janczy-Cempa E; Gajda-Morszewski P; Mazuryk O
J Inorg Biochem; 2022 Jan; 226():111652. PubMed ID: 34741931
[TBL] [Abstract][Full Text] [Related]
2. Unexplored features of Ru(ii) polypyridyl complexes - towards combined cytotoxic and antimetastatic activity.
Gurgul I; Mazuryk O; Łomzik M; Gros PC; Rutkowska-Zbik D; Brindell M
Metallomics; 2020 May; 12(5):784-793. PubMed ID: 32227043
[TBL] [Abstract][Full Text] [Related]
3. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Notaro A; Gasser G
Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
[TBL] [Abstract][Full Text] [Related]
4. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of Ru(II) Polypyridyl Complexes into Nanomaterials for Cancer Therapy and Diagnosis.
Soliman N; Gasser G; Thomas CM
Adv Mater; 2020 Nov; 32(47):e2003294. PubMed ID: 33073433
[TBL] [Abstract][Full Text] [Related]
6. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.
Čanović P; Simović AR; Radisavljević S; Bratsos I; Demitri N; Mitrović M; Zelen I; Bugarčić ŽD
J Biol Inorg Chem; 2017 Oct; 22(7):1007-1028. PubMed ID: 28695374
[TBL] [Abstract][Full Text] [Related]
7. The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
Mazuryk O; Suzenet F; Kieda C; Brindell M
Metallomics; 2015 Mar; 7(3):553-66. PubMed ID: 25711770
[TBL] [Abstract][Full Text] [Related]
8. Bifunctional ruthenium(ii) polypyridyl complexes of curcumin as potential anticancer agents.
Li S; Xu G; Zhu Y; Zhao J; Gou S
Dalton Trans; 2020 Jul; 49(27):9454-9463. PubMed ID: 32598409
[TBL] [Abstract][Full Text] [Related]
9. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
[TBL] [Abstract][Full Text] [Related]
10. Arene ruthenium(II) Complexes: The Promising Chemotherapeutic Agent in Inhibiting the Proliferation, Migration and Invasion.
Zheng K; Wu Q; Ding Y; Mei W
Mini Rev Med Chem; 2016; 16(10):796-803. PubMed ID: 26423698
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
[TBL] [Abstract][Full Text] [Related]
12. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
13. Photoinduced synergistic cytotoxicity towards cancer cells
Han Z; Chen Y; Wang Y; Shi X; Yuan H; Bai Y; Chen Z; Fang H; He W; Guo Z
Dalton Trans; 2020 Oct; 49(40):13954-13957. PubMed ID: 33000850
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium Complexes as Promising Candidates against Lung Cancer.
Sun Q; Li Y; Shi H; Wang Y; Zhang J; Zhang Q
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361543
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, spectral studies, DNA binding, photocleavage, antimicrobial and anticancer activities of isoindol Ru(II) polypyridyl complexes.
Ravi C; Vuradi RK; Avudoddi S; Yata PK; Putta VR; Srinivas G; Merugu R; Satyanarayana S
Nucleosides Nucleotides Nucleic Acids; 2019; 38(10):788-806. PubMed ID: 31081456
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Jakubaszek M; Goud B; Ferrari S; Gasser G
Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic and anticancer properties of new ruthenium polypyridyl complexes with different lipophilicities.
Florence Tikum A; Jeon YJ; Lee JH; Park MH; Bae IY; Kim SH; Lee HJ; Kim J
J Inorg Biochem; 2018 Mar; 180():204-210. PubMed ID: 29329027
[TBL] [Abstract][Full Text] [Related]
18. Disaggregation of human islet amyloid polypeptide fibril formation by ruthenium polypyridyl complexes.
Zhu D; Gong G; Wang W; Du W
J Inorg Biochem; 2017 May; 170():109-116. PubMed ID: 28231451
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole-Containing Ruthenium Complexes.
Liu P; Jia J; Zhao Y; Wang KZ
Mini Rev Med Chem; 2016; 16(4):272-89. PubMed ID: 26586123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
